Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis
2023 Symposium Highlights – Article

Atopic Dermatitis and Prurigo Nodularis: Dupilumab Therapy and Disease Control Highlights from the 32nd EADV Congress DOWNLOAD PDF VERSION Abstract The 32nd European Academy of Dermatology and Venereology Congress was held between October 11th and 14th 2023 in Berlin, Germany. During the event, Prof. Stephan Weidinger, from the University Hospital Schleswig-Holstein, Germany, discussed the role […]

Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis
2023 Symposium Highlights – Article
Read More »

Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis
2023 Symposium Highlights – Video

Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis 2023 EADV Congress Symposium ‘Itch is Only the Beginning: Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis’ In this video summary, Dr Raj Chovatiya from Northwestern University, Chicago, Professor Martin Metz from Charité – Universitätsmedizin, Germany and Dr Andreas Pinter from Goethe University, Germany discussed

Achieving Disease Control in Atopic Dermatitis and Prurigo Nodularis
2023 Symposium Highlights – Video
Read More »

Expanding Biologic Therapy in Atopic Dermatitis
2023 Symposium Highlights – Video

Expanding Biologic Therapy in Atopic Dermatitis​ 2023 EADV Congress Symposium The Revolution Continues: Expanding Biologic Therapy in Atopic Dermatitis In this video summary, Professor Stephan Weidinger, Germany, Professor Emma Guttman-Yassky, USA and Professor Adam Friedman, USA discuss the latest scientific knowledge in type 2 inflammation and its role in pathophysiology of atopic dermatitis (AD), how

Expanding Biologic Therapy in Atopic Dermatitis
2023 Symposium Highlights – Video
Read More »

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent
2023 Symposium Highlights – Video

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent Highlights from the 2023 EADV ‘Atopic Dermatitis Knowledge Challenge – an Education Symposium’ In this video summary, Dr. Ignasi Figueras from the University of Barcelona and Dr. Alexandra Golant from Mount Sinai Hospital, USA, discussed the disease burden, pathophysiology, and effectiveness of Dupixent—the first treatment approved

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent
2023 Symposium Highlights – Video
Read More »

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent
2023 Symposium Highlights – Article

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent Highlights from the 2023 EADV ‘Atopic Dermatitis Knowledge Challenge – an Education Symposium’ DOWNLOAD PDF VERSION Abstract The ‘Atopic Dermatitis Knowledge Challenge – an Education Symposium’ was conducted on May 19th 2023 as a part of the European Academy of Dermatology and Venereology’s Spring Symposium series.

Atopic Dermatitis: Disease Burden, Pathophysiology, and Treatment with Dupixent
2023 Symposium Highlights – Article
Read More »

Atopic Dermatitis Knowledge Challenge: An Educational Symposium
2022 Symposium Highlights – Article

KOM – Atopic Dermatitis Knowledge Challenge: An Educational Symposium DOWNLOAD PDF VERSION KOM Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease characterised by intense pruritus and typical skin lesions that has a significant impact on both patients and their families. It can affect daily activities and work productivity1 and accounts for a significant portion

Atopic Dermatitis Knowledge Challenge: An Educational Symposium
2022 Symposium Highlights – Article
Read More »